Nucleate announces launch of Northeast Regional Innovation Hub in partnership with B+Labs

3 min readSep 11, 2023


Nucleate, an international nonprofit organization led by academic trainees, is dedicated to empowering future biotech leaders. Together with B+Labs, a life science incubation site in the Schuylkill Yards area of University City, Philadelphia, PA — operated by Brandywine REIT and the Pennsylvania Biotechnology Center (PABC) — we are excited to announce a collaboration to operate the Northeast Regional Innovation HUB (NRIH).

This NRIH location at B+Labs will serve as a landing spot for Nucleate-affiliated companies in the US Northeast region seeking to de-risk and progress their novel medicine assets and programs. With 12 months of flexible lease terms and no-cost baseline operations, the NRIH program will enable foundation- and early-stage Nucleate companies to progress their science in a highly efficient fashion. And by locating within the University City area of Philadelphia, NRIH companies will be able to access the network of preclinical and clinical experts and KOLs that are critical to the growth of early-stage therapeutic companies.

“B+Labs is excited to launch this HUB initiative with Nucleate in Philadelphia. Nucleate has been leading the way with emerging scientists and company builders from top global academic organizations, and that’s what we are interested in at B+Labs and in Philadelphia: enabling the next generation of founders to validate clinical utility of diverse assets and technologies. Our HUB strategy with Nucleate will play a key role towards that end.”

“The first of its kind HUB will address many of the pain points that new companies face in early development. By providing funded lab space, mentorship from the industry’s finest, early exposure to investors and experts, companies who have completed the rigorous Nucleate activator curriculum companies will be inherently de-risked. All of this provided with zero equity stakes” Hilary Schultz, EIR at B+Labs and acting EVP of Organizational Development at Nucleate.

We are considering applications for the NRIH program on a rolling basis until September 25th. The application can be completed at

Nucleate remains steadfast in its mission: to democratize, disseminate, and aid zealous biotech founders in achieving success. This includes providing access to advisors, funding, and programs. We aim to grow this partnership year over year and scale across our global footprint.

About B+Labs

B+Labs is an early- and growth-stage incubation space for life science companies developing novel medicines across numerous modalities and indications. Located at 30th Street Station within Cira Centre and at the entryway to University City, B+Labs houses 20 private lab suites over two floors (50,000 sq ft) totaling 191 wet benches with additional private office suites and dedicated office space. Additional shared-access lab suites include equipment and instruments that enable emerging companies to operate at a scale and speed that would be unattainable with independent operations. The B+Labs site is an elite location to place a company for growth, networking, and integration into the Philadelphia, as well as a global, life science ecosystem.

About Nucleate

Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 23 geographic regions and participation from over 120 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit for more information.